Related Experiment Video
Updated: Mar 23, 2026

06:11
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
10.4K
Place-Based Disparities in Treatment and Time-to-Initiation for Head and Neck Cancer
Anders Erickson1, Jason Semprini1
1Department of Public Health, Des Moines University, West Des Moines, Iowa, USA.
Summary
Patients in low-income counties receive less timely head and neck cancer (HNC) treatment and are more likely to receive non-surgical care. These findings highlight disparities in HNC care patterns post-diagnosis.
Area of Science:
- Oncology
- Health Services Research
- Health Disparities
Background:
- Head and neck cancer (HNC) affects over 72,000 US adults annually.
- Persistent place-based disparities exist in HNC outcomes, particularly after diagnosis.
- Limited research addresses post-diagnosis care patterns and their geographic variations.
Purpose of the Study:
- To investigate disparities in head and neck cancer (HNC) treatment patterns based on county income level.
- To analyze differences in treatment type and timeliness between patients in low-income versus high-income counties.
- To identify potential inequities in the delivery of HNC care.
Main Methods:
- Utilized an observational, repeated cross-sectional design with Surveillance, Epidemiology, and End Results (SEER) case data (2018-2022).
- Analyzed treatment outcomes: surgery only, surgery with adjuvant radiotherapy, definitive chemoradiation, radiation/chemotherapy alone, or no treatment.
- Examined time from diagnosis to treatment initiation (0-29, 30-59, 60-89, 90+ days) using regression models adjusted for confounders.
Main Results:
- No significant place-based differences were found for adjuvant or definitive treatments.
- Patients in low-income counties were less likely to receive surgery only and more likely to receive radiation or chemotherapy alone.
- Patients in low-income counties were less likely to start treatment within 0-29 days and more likely to experience treatment delays (60-89 days).
Conclusions:
- Place-based disparities in head and neck cancer (HNC) treatment patterns persist, particularly concerning timeliness and treatment modality.
- System-level interventions are crucial to ensure equitable access to high-quality, timely HNC care in low-income communities.
- Further research should evaluate the impact of interventions aimed at reducing HNC care disparities.
Related Concept Videos
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Cancer Survival Analysis
820
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
820
Treatment Resistent Cancers
1.5K
1.5K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K

